中裕新藥股份有限公司
該股 RSI(6) 為 65.6，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日、120日均線，跌破60日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=57.3）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
中裕新藥股份有限公司（TaiMed Biologics Inc.）開發與商業化用於治療及預防感染性疾病的藥物。公司銷售用於愛滋病（HIV）治療的單株抗體藥物「Trogarzo」。目前正開發 HIV 預防用抗體 TMB-365 以及抗癌用抗體藥物複合體。公司成立於 2007 年，總部位於台灣台北。
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 11-10 | +168 | 0 | +3 | +171 |
| 11-09 | +526 | 0 | 0 | +526 |
| 11-06 | +721 | 0 | -1 | +720 |
| 11-05 | +42 | 0 | 0 | +42 |
| 11-04 | +106 | 0 | +1 | +107 |
| 11-03 | +64 | 0 | -1 | +63 |
| 11-02 | -136 | 0 | -2 | -137 |
| 10-30 | -510 | 0 | -1 | -511 |
| 10-29 | +25 | 0 | -1 | +24 |
| 10-28 | -163 | 0 | 0 | -164 |
| 10-27 | +115 | 0 | 0 | +115 |
| 10-22 | +8 | 0 | 0 | +7 |
| 10-21 | +530 | 0 | +3 | +533 |
| 10-20 | +264 | 0 | +1 | +265 |
| 10-19 | -231 | 0 | +2 | -229 |
| 10-16 | +300 | 0 | +1 | +301 |
| 10-15 | +126 | 0 | +2 | +128 |
| 10-14 | +149 | 0 | +1 | +150 |
| 10-13 | -474 | 0 | -10 | -484 |
| 10-12 | -17 | 0 | -2 | -18 |
| 10-08 | -63 | 0 | -1 | -64 |
| 10-07 | +233 | 0 | +3 | +236 |
| 10-06 | +236 | 0 | 0 | +236 |
| 10-05 | -367 | 0 | -2 | -368 |
| 10-02 | -149 | 0 | -1 | -150 |
| 10-01 | -507 | 0 | -1 | -508 |
| 09-30 | +238 | 0 | +7 | +245 |
| 09-29 | +268 | 0 | +1 | +269 |
| 09-24 | -412 | 0 | -3 | -415 |
| 09-23 | +441 | 0 | +2 | +443 |
| 09-22 | +484 | 0 | +3 | +487 |
| 09-21 | +379 | 0 | +1 | +379 |
| 09-18 | -26 | 0 | +1 | -25 |
| 09-17 | +450 | 0 | 0 | +450 |
| 09-16 | +82 | 0 | +1 | +83 |
| 09-15 | -44 | 0 | +1 | -43 |
| 09-14 | -22 | 0 | 0 | -22 |
| 09-11 | -358 | 0 | -1 | -359 |
| 09-10 | -65 | 0 | +1 | -64 |
| 09-09 | -619 | 0 | -2 | -621 |
| 09-08 | +444 | 0 | +1 | +445 |
| 09-07 | -9 | 0 | -1 | -10 |
| 09-04 | +140 | 0 | 0 | +140 |
| 09-03 | +139 | 0 | +1 | +140 |
| 09-02 | +154 | 0 | 0 | +154 |
| 09-01 | -240 | 0 | 0 | -240 |
| 08-31 | -312 | 0 | 0 | -312 |
| 08-28 | -1,211 | 0 | -4 | -1,215 |
| 08-27 | +416 | 0 | +2 | +418 |
| 08-26 | +303 | 0 | +1 | +304 |
| 08-25 | +193 | 0 | -1 | +192 |
| 08-24 | +224 | 0 | 0 | +223 |
| 08-21 | +428 | 0 | +1 | +429 |
| 08-20 | +295 | 0 | 0 | +295 |
| 08-19 | +74 | 0 | 0 | +74 |
| 08-18 | +80 | 0 | 0 | +80 |
| 08-17 | -340 | 0 | -2 | -342 |
| 08-14 | -140 | 0 | -1 | -141 |
| 08-13 | -326 | 0 | -4 | -330 |
| 08-12 | +64 | 0 | +1 | +65 |
| 08-11 | +860 | 0 | 0 | +860 |
| 08-10 | +391 | 0 | -1 | +391 |
| 08-07 | -279 | 0 | 0 | -279 |
| 08-06 | -75 | 0 | 0 | -75 |
| 08-05 | +162 | 0 | +3 | +165 |
| 08-04 | +36 | 0 | -26 | +10 |
| 08-03 | +270 | 0 | -2 | +267 |
| 07-31 | -446 | 0 | +30 | -416 |
| 07-30 | +85 | 0 | +1 | +86 |
| 07-29 | +347 | 0 | +2 | +349 |
| 07-28 | +235 | 0 | 0 | +235 |
| 07-27 | +136 | 0 | 0 | +135 |
| 07-24 | -59 | 0 | 0 | -59 |
| 07-23 | -1 | 0 | +2 | 0 |
| 07-22 | -142 | 0 | -1 | -144 |
| 07-21 | -199 | 0 | -1 | -200 |
| 07-20 | +191 | 0 | -1 | +190 |
| 07-17 | -49 | 0 | +1 | -48 |
| 07-16 | -277 | 0 | 0 | -278 |
| 07-15 | -24 | 0 | -1 | -25 |
| 07-14 | -1 | 0 | 0 | -1 |
| 07-13 | -648 | 0 | -5 | -653 |
| 07-09 | -57 | 0 | -1 | -58 |
| 07-08 | -177 | 0 | 0 | -178 |
| 07-07 | -126 | 0 | +1 | -125 |
| 07-06 | -32 | 0 | +1 | -32 |
| 07-03 | +1,065 | 0 | -3 | +1,062 |
| 07-02 | -331 | 0 | +1 | -330 |
| 07-01 | -594 | 0 | 0 | -594 |
| 06-30 | -203 | 0 | -1 | -204 |
| 06-29 | -137 | 0 | -1 | -138 |
| 06-26 | -119 | 0 | -73 | -192 |
| 06-25 | -9 | 0 | 0 | -9 |
| 06-24 | -794 | 0 | -5 | -799 |
| 06-23 | +476 | 0 | +5 | +481 |
| 06-22 | +125 | 0 | +1 | +126 |
| 06-18 | +186 | 0 | +1 | +187 |
| 06-17 | +16 | 0 | 0 | +16 |
| 06-16 | -30 | 0 | 0 | -30 |
| 06-15 | -104 | 0 | +1 | -103 |
| 06-12 | -842 | 0 | 0 | -841 |
| 06-11 | -812 | 0 | +5 | -807 |
| 06-10 | +64 | 0 | 0 | +64 |
| 06-09 | -20 | 0 | -1 | -21 |
| 06-08 | +57 | 0 | +1 | +57 |
| 06-05 | -444 | 0 | -1 | -445 |
| 06-04 | -114 | 0 | +1 | -113 |
| 06-03 | -103 | 0 | 0 | -103 |
| 06-02 | -210 | 0 | 0 | -210 |
| 06-01 | +709 | 0 | 0 | +709 |
| 05-29 | +481 | 0 | +1 | +481 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/10 | 5243 萬 | -2.7% | +35.7% |
| 2026/09 | 5387 萬 | -10.9% | -9.1% |
| 2026/08 | 6047 萬 | -5.0% | +19.5% |
| 2026/07 | 6369 萬 | +40.7% | +68.4% |
| 2026/06 | 4526 萬 | -28.6% | -16.9% |
| 2026/05 | 6334 萬 | +34.1% | +42.9% |
| 2026/04 | 4723 萬 | -39.8% | +21.8% |
| 2026/03 | 7843 萬 | +57.6% | +0.5% |
| 2026/02 | 4977 萬 | +31.4% | +2.9% |
| 2026/01 | 3788 萬 | -48.3% | -24.0% |
| 2025/12 | 7333 萬 | +93.3% | +56.9% |
| 2025/11 | 3793 萬 | - | -33.7% |